The autophagy-enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado-Joseph disease.
Ana Vasconcelos-FerreiraSara Carmo-SilvaJosé Miguel CodêssoPatrick SilvaAlberto Rolim Muro MartinezMarcondes Cavalcante de França JuniorClevio NobregaLuis Pereira de AlmeidaPublished in: Neuropathology and applied neurobiology (2021)
Our data support the autophagy-enhancing activity of CBZ in the brain and suggest this pharmacological approach as a promising therapy for MJD and other polyglutamine disorders.